AN2 Therapeutics, Inc.
ANTX
$5.73
-$0.25-4.18%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -8.09% | 47.05% | -6.33% | -1.58% | -6.18% |
| Total Receivables | -70.00% | 11.11% | 50.00% | 50.00% | 33.33% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 8.40% | 16.12% | -30.70% | -64.47% | 91.36% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -8.57% | 45.97% | -6.37% | -5.20% | -2.93% |
|
|
|||||
| Total Current Assets | -8.57% | 45.97% | -6.37% | -5.20% | -2.93% |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -6.65% | 41.23% | -7.86% | -11.33% | -6.78% |
|
|
|||||
| Total Accounts Payable | -24.78% | -13.44% | 35.71% | 5.35% | -31.24% |
| Total Accrued Expenses | 19.41% | -46.76% | 0.47% | 7.13% | -9.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 36.86% | -53.86% | 571.58% | -74.48% | 94.31% |
| Total Other Current Liabilities | 36.86% | -53.86% | 571.58% | -74.48% | 94.31% |
| Total Current Liabilities | 0.41% | -36.22% | 27.15% | -1.79% | -12.86% |
|
|
|||||
| Total Current Liabilities | 0.41% | -36.22% | 27.15% | -1.79% | -12.86% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 0.00% | 0.00% | -- | -- | -- |
| Total Liabilities | 0.40% | -35.52% | 29.63% | -1.79% | -12.86% |
|
|
|||||
| Common Stock & APIC | 0.71% | 13.20% | 0.48% | 0.29% | 0.69% |
| Retained Earnings | -3.26% | -4.16% | -3.75% | -4.20% | -2.99% |
| Treasury Stock & Other | -360.00% | -108.77% | -10.94% | 156.00% | -47.92% |
| Total Common Equity | -7.14% | 54.09% | -12.12% | -12.30% | -6.12% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -7.14% | 54.09% | -12.12% | -12.30% | -6.12% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -7.14% | 54.09% | -12.12% | -12.30% | -6.12% |
|
|
|||||